$4.93Average Price Target
The highest estimate is 4.93.
From 1 ratings within the last 6 months. This is not an investment recommendation.
This list is based on the watchlists of people on Stock Events who follow ACU2.MU. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.
FAQs
What is Amundi PEA MSCI USA ESG Selection UCITS - EUR stock price today?▼
The current price of ACU2.MU is €816.00 EUR — it has decreased by -3.88% in the past 24 hours. Watch Amundi PEA MSCI USA ESG Selection UCITS - EUR stock price performance more closely on the chart.
What is Amundi PEA MSCI USA ESG Selection UCITS - EUR stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Amundi PEA MSCI USA ESG Selection UCITS - EUR stocks are traded under the ticker ACU2.MU.
Is Amundi PEA MSCI USA ESG Selection UCITS - EUR stock price growing?▼
ACU2.MU stock has fallen by -4.37% compared to the previous week, the month change is a -6.62% fall, over the last year Amundi PEA MSCI USA ESG Selection UCITS - EUR has showed a +15.1% increase.
What is Amundi PEA MSCI USA ESG Selection UCITS - EUR market cap?▼
Today Amundi PEA MSCI USA ESG Selection UCITS - EUR has the market capitalization of 164.44B
When is the next Amundi PEA MSCI USA ESG Selection UCITS - EUR earnings date?▼
Amundi PEA MSCI USA ESG Selection UCITS - EUR is going to release the next earnings report on February 25, 2027.
What were Amundi PEA MSCI USA ESG Selection UCITS - EUR earnings last quarter?▼
ACU2.MU earnings for the last quarter are 0 EUR per share, whereas the estimation was -0.01 EUR resulting in a +100% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Amundi PEA MSCI USA ESG Selection UCITS - EUR revenue for the last year?▼
Amundi PEA MSCI USA ESG Selection UCITS - EUR revenue for the last year amounts to 202.53M EUR.
What is Amundi PEA MSCI USA ESG Selection UCITS - EUR net income for the last year?▼
ACU2.MU net income for the last year is -13.85M EUR.
How many employees does Amundi PEA MSCI USA ESG Selection UCITS - EUR have?▼
As of November 7, 2026, the company has 345 employees.
In which sector is Amundi PEA MSCI USA ESG Selection UCITS - EUR located?▼
Amundi PEA MSCI USA ESG Selection UCITS - EUR operates in the Health & Wellness sector.
When did Amundi PEA MSCI USA ESG Selection UCITS - EUR complete a stock split?▼
Amundi PEA MSCI USA ESG Selection UCITS - EUR has not had any recent stock splits.
Where is Amundi PEA MSCI USA ESG Selection UCITS - EUR headquartered?▼
Amundi PEA MSCI USA ESG Selection UCITS - EUR is headquartered in CONCORD, United States.